The PRWIRE Press Releases https:// 2020-07-28T09:49:00Z Epazz DeskFlex Desk and Room Scheduling System Automates Desk Sanitation as Preventive Measure to Combat COVID-19 Infection in the Workplace 2020-07-28T09:49:00Z epazz-deskflex-desk-and-room-scheduling-system-automates-desk-sanitation-as-preventive-measure-to-combat-covid-19-infection-in-the-workplace-1      Desk Scheduling System Helps Prevent the Onset of COVID-19 Infection in the Workplace with its Automatic Scheduling of Cleaning July 27, 2020 - (ACN Newswire) - via NEWMEDIAWIRE - Epazz, Inc. (OTC: EPAZ), a cloud-computing software company announced today that the DeskFlex desk and room scheduling system reconfigures its systems to include an automatic desk sanitation feature to prevent the onset or spread of the infection known as COVID-19 in workspaces.DeskFlex's automatic scheduling desk sanitation is a program system configuration that allows the sanitation team to disinfect and clean desks, meeting rooms, workstations, conference rooms, and office equipment in between reservations. DeskFlex's room scheduling system activates desk sanitation after the ending of a reservation. It provides a 30-minute time gap to allow the cleaning crew to wipe, spray on, and sanitize the desks and frequently used items such as telephones.DeskFlex's room booking system aspires to keep business establishments, schools, universities, organizations, and enterprises free from the COVID-19 infection. With the automation of desk sanitation in between reservations. The chances of spreading viral or bacterial particles in the workspace will lessen between each user.DeskFlex's desk booking software has been in business since 1997 and is an exceptional desk hoteling and intelligent conference room booking software that is extremely useful in many industries including Health, Education, Business, Government, and Enterprise. Epazz acquired DeskFlex in 2008 and has been making major updates to the office hoteling system.DeskFlex's room scheduling software upholds its mission in improving the lives of our customers' employees by providing accessible, user-friendly, reliable, and performance-driven desk hoteling and total office management software tools especially in challenging times like the current COVID-19 pandemic.DeskFlex's room reservation online works hard to accommodate the surge of product requests coming from small and large organizations here and abroad. As the world returns to its office spaces, more and more organizations recognize the need for intelligent room booking software solutions that can help in preventing COVID-19 contamination in the workplace.According to Shaun Passley, Ph.D., CEO of Epazz, Inc., "We are pleased to announce that DeskFlex's room booking software is now more adept in preventing COVID-19 infections from happening in the workplace by automating the cleaning of desks and rooms. Our team is working hard to improve our room scheduling system that includes preventive measures in combatting epidemics and maintaining a safe environment in the office."About DeskFlex.comDeskFlex is a desk booking solution and room reservation software for conference rooms, workspaces, car parking spaces, and equipment which helps office managers accommodate the occasional needs of mobile workers while reducing rent and facility costs. DeskFlex lets employees reserve a space in advance or claim desks right away. It adjusts the telephone switch (PBX), so calls ring at the "desk du jour." DeskFlex includes check-in, point-and-click floor maps, a web browser, a local kiosk, Outlook integration, and conference room scheduling.About Epazz, Inc. (www.epazz.com)Epazz, Inc., is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz BoxesOS(TM) v3.0 is a complete web-based software package for small- to midsize businesses, Fortune 500 enterprises, government agencies, and higher education institutions. BoxesOS provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz's other products are K9Sky.com kennel software and the Provitrac applicant tracking system.SAFE HARBORThis is the "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: certain statements contained in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of forward-looking words such as "may," "expect," "intend," "estimate," "anticipate," "believe," and "continue" (or the negation thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that no forward-looking statement is a guarantee of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz, Inc. assumes no obligation and has no intention of updating these forward-looking statements. It has no obligation to update or correct information prepared by third parties that are not paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.'s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC market filings, which contain general business information about the company's operations, results of operations, and risks associated with the company and its operations.CONTACT: For more information, please contactInvestor Relationsinvestors@epazz.net(312) 955-8161www.epazz.com Madeline 'Maddy' Cross-Parkin Appointed Director of Music Grants, The Scheer Foundation 2020-07-21T20:53:54Z madeline-maddy-cross-parkin-appointed-director-of-music-grants-the-scheer-foundation Beverly Hills, CA and Brisbane, AU, July 22, 2020 - (ACN Newswire) - The Scheer Foundation announced today the appointment of Ms. Madeline "Maddy" Cross-Parkin as Director of Music Grants, effective July 14, 2020. Maddy, who was chosen after an international search, is a brilliant pianist currently following a cursus at the University of Queensland in Brisbane, Australia. Maddy will lead the Music Grants allocation of the Foundation, and will develop a strategic plan for the Foundation music initiatives. Maddy will have the ultimate decision in granting assistance to young artists.The Scheer Foundation historically has been operated in the fight against malnutrition but has recently expanded its reach to Arts & Music. The Scheer Foundation is committed to serving the fields of classical music in supporting promising young artists."The world of music is international and does not know borders. Music bring peace and joy around the world and therefore we have decided to dedicate some of our efforts to Music," said Frederic Scheer, Chairman of the Foundation."Maddy is young, a brilliant artist and her energy and dedication will bring joy to a lot of people. I salute her willingness to participate in this new adventure. It is rare to see young people volunteering for helping others, we are privileged and happy to welcome her."About the Scheer FoundationThe Frederic & Jocelyne Scheer Foundation is a US Private Foundation dedicated to fighting malnutrition and child mortality in Africa and promoting local agricultural and industrial project to build up local and regional employment. The Foundation recently expanded its reach to Arts & Music.Learn more at www.scheerfoundation.info. Episode Six Secures $7 Million to Accelerate Global Growth as Demand for Digital Transformation Increases 2020-07-21T13:22:27Z episode-six-secures-7-million-to-accelerate-global-growth-as-demand-for-digital-transformation-increases      July 21, 2020 - Episode Six, a next-generation financial technology provider, today announced that it has secured $7 million of its Series A funding. The round was led by HSBC and includes investments from Mastercard and SBI Investment Co., Ltd., which first invested in Episode Six through its FinTech Business Innovation Fund in 2017."Financial institutions and innovators in other industries like healthcare are beginning to realize the constraints of legacy technology, especially given the increasing demand for new products and streamlined efficiencies," said Episode Six CEO John Mitchell. "We have developed financial technology which, via more than 500 APIs, facilitates that next level of configurability for companies looking to digitize their account and payments infrastructure or launch new products and solutions. We are pleased our investors share the same vision of helping businesses bring their offerings into the future."In the past year, Episode Six has expanded its footprint in three of the world's largest financial markets - Tokyo, Singapore and London, and rolled out its latest technology enhancements, IONIC and Vertices, which allow for unprecedented flexibility and innovation in creating state-of-the-art, customer-centric financial and payments products. With this new funding, Episode Six will continue to grow and expand globally, delivering enhanced technology that powers digital transformation for companies and institutions in financial services, fintech, health tech and more."Episode Six has proven the power of its technology in Asia-Pacific, helping us develop digital wallet propositions to better serve our customers," said Brian McKenney, Chief Innovation Officer of HSBC's Global Liquidity and Cash Management division. "We look forward to exploring opportunities for expanding our product roadmap with Episode Six across other markets in the future."Jason Lane, Executive Vice President, Market Development Europe at Mastercard noted: "Mastercard is committed to drive the digital economy making lives simple, seamless and secure. Fostering innovative banking services is essential for us to realize this commitment. To that end, we're pleased to support Episode Six in its endeavor to expand its activities in Europe."Currently, 3 million consumers and businesses use products built using Episode Six technology. DLA Piper, a multinational law firm, served as counsel for the Company's Series A. For more on Episode Six's future-proofed financial technology, visit www.episodesix.com.About Episode SixEpisode Six provides a next-generation financial technology platform for creating innovative and differentiated financial and payments products for consumers and businesses, enabling financial institutions, fintechs and other innovative companies to serve their customers better. Episode Six was founded by payments pioneers with the mission of redefining what is possible in the financial services and payments industries - industries that are increasingly burdened with inflexible legacy technology, which severely limits product evolution and innovation. Episode Six's proprietary, innovative technology was built from scratch and was architected to be future-proofed. It provides unparalleled product customization and on-demand product management capabilities. It is portable and compatible for use anywhere in the world with easy installation, integration and connection facilitated by an extensive and comprehensive set of APIs. Episode Six makes it possible for companies of all sizes to effortlessly design and manage products that consumers and businesses want and need. For more information, visit www.EpisodeSix.com. Privity participates in Verofax pre-seed investment round 2020-07-07T08:30:30Z privity-participates-in-verofax-limited-s-pre-seed-investment-round          DUBAI, UAE, July 6, 2020 - Verofax Limited, a start-up building innovative Traceability services with the application of blockchain, closed its recent pre-seed investment round with participation from Privity FZ LLE, based in the UAE, acquiring an equity stake. Privity is an independent venture-focused advisory firm, founded in Dubai in 2004, that has backed and invested in more than a dozen portfolio companies since its inception.Wassim Merheby, Verofax CEO, commented, "We are truly thrilled to welcome Privity as a shareholder in Verofax. Traceability plays a key role in upgrading brand owners' business through authenticity validation, advanced product marketing and access to financing and global markets. Traceability is a key enabler of digital transformation to automated and resilient supply chain services. In the markets where Traceability has been deployed such as China, sales increased by over 30% while consumer complaints dropped by 42%. It is just a matter of time for Traceability to become a must for ShopSafe compliance regulations, currently under review in the US for example."Mr. Merheby is leading transformation projects for the Health authorities in UAE in relation to eHealth native digital services, and promoting patient safety through the application of integrated technologies. The world has just been hit by a pandemic which clearly points out that Healthcare could be better managed with contactless processes applying technologies such as IOT devices, drones, blockchain, AI, and augmented reality. The most immediate need is for the safe delivery of eHealth services, where Verofax offers wide applicability for the underlying systems of the Healthcare and supply chain industries.Sleem Hasan, Privity Founder and CEO, said "Privity participated alongside reputed regional investors in the pre-seed round of investment in Verofax. This is Privity's first portfolio company based in the UAE, and its second HealthTech venture. I am delighted to open Privity's network to Verofax as I find the underlying value proposition of their business idea compelling. COVID-19 has demonstrated the need to transform secure delivery and offer protection to the most vulnerable in our society. Verofax services are perfectly positioned and aligned to secure pharmaceutical deliveries of medication in the region with privacy and safety."Verofax proprietary traceability and delivery solutions powers unique compliance and brand protection services, including serialization, traceability, anti-counterfeit and anti-diversion solutions. The service supports manufacturers of food, pharmaceuticals and other consumer goods, in meeting evolving product traceability regulations and growing consumer demand for product safety, security and authenticity.About VerofaxVerofax Limited is a blockchain-enabled, traceability service provider established in Abu Dhabi Global Markets, UAE. Verofax services have been accepted by Oracle, Microsoft and Ant Group for co-selling across their established B2B channels. Verofax has recently set up subsidiary entities in Malaysia and Estonia, to offer Traceability-as-a-service across wider geographies.About PrivityPrivity FZ LLE was founded in 2004, an independent venture-focused advisory firm that seeks entrepreneurs with interesting and unique ideas and helps them develop and grow. Privity is agnostic to geography and industry vertical; It focuses on the quality of the entrepreneur and the compelling value proposition of the idea.Visit Verofax at https://verofax.com, and Privity FZ LLE at http://www.privitylle.com. Five Advisors With Focus Partner Firm Escala Partners Named to Australia's Top 100 Financial Advisers 2020 List 2020-07-03T03:25:20Z five-advisors-with-focus-partner-firm-escala-partners-named-to-australia-s-top-100-financial-advisers-2020-list      July 3, 2020 - Focus Financial Partners Inc. (NASDAQ: FOCS) ("Focus"), a leading partnership of fiduciary wealth management firms, announced today that five advisors with Melbourne-based Escala Partners Limited ("Escala"), a Focus partner firm, were named to Australia's Top 100 Financial Advisers List 2020. The list is based on an extensive, national survey conducted by Barron's and The Australian's business magazine The Deal, and is a guide to the country's leading wealth management advisors.Escala was established with the collective ambition to become the new standard of personalized wealth management in Australia. The firm quickly emerged as a leading fiduciary wealth advisor to individuals, families, foundations and institutional investors across Australia, providing them with customized investment solutions through a collaborative, team-based approach. Escala's client relationships are sustained over time through their dedication to highly personalized service and an ongoing commitment to innovation in defining the standards for excellence in the Australian wealth management industry.Mason Allamby, Scott Carmichael, Steve Collins, Amanda Fong and Ben James are Partners and members of the original group of Escala founders who started the firm in 2013. They each have deep expertise in multiple areas of wealth management, including financial planning, asset allocation, tax strategy and, in Ms. Fong's case, the not-for-profit space."We are honored to have such an impressive group of our advisors named to the Top 100 Financial Advisors list," said Pep Perry, CEO of Escala. "They embody the collaborative approach and dedication to client service that are the foundation of Escala and make our firm uniquely successful.""We are thrilled for Escala on receiving this important recognition," said Rajini Kodialam, Co-Founder and Chief Operating Officer of Focus. "Their team of talented advisors are leaders in their field and have been at the forefront of the evolution of the Australian wealth management industry. Their passion for excellence is at the core of everything that they do for their clients and positions them for strong growth in the years ahead."About Focus Financial Partners Inc.Focus Financial Partners Inc. is a leading partnership of fiduciary wealth management firms. Focus provides access to best practices, resources, and continuity planning for its partner firms who serve individuals, families, employers and institutions with comprehensive wealth management services. Focus partner firms maintain their operational autonomy, while they benefit from the synergies, scale, economics and best practices offered by Focus to achieve their business objectives. For more information about Focus, please visit www.focusfinancialpartners.com.About Escala Partners LimitedFounded in 2013, Escala provides objective advice and investment management solutions to high net worth individuals, families, foundations and institutional investors. Escala serves its clients through a collaborative, team-based approach focused on the client experience, a relationship built on trust and sustained over time by performance in line with evolving investment objectives. For more information about Escala, please visit https://escalapartners.com.au.About The Australia's Top 100 Financial Advisers List 2020 RankingsBarron's and The Australian's business magazine The Deal rank investment advisers based on client assets managed by the adviser, fees and revenue generated by their business, and the quality of the adviser's business (as measured by factors including the adviser's experience, credentials, client-service resources, and charitable and philanthropic work).Cautionary Note Concerning Forward-Looking StatementsThis release contains certain forward-looking statements that reflect Focus' current views with respect to certain current and future events. These forward-looking statements are and will be, subject to many risks, uncertainties and factors relating to Focus' operations and business environment, including, without limitation, uncertainty surrounding the current COVID-19 pandemic, which may cause future events to be materially different from these forward-looking statements or anything implied therein. Any forward-looking statements in this release are based upon information available to Focus on the date of this release. Focus does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any statements expressed or implied therein will not be realized. Additional information on risk factors that could affect Focus may be found in Focus' filings with the Securities and Exchange Commission.Any services described in this release are not intended for United States persons.Investor and Media ContactTina MadonSenior Vice PresidentHead of Investor Relations & Corporate CommunicationsFocus Financial PartnersP: +1-646-813-2909tmadon@focuspartners.com Standard Chartered and HKTDC Launch 'Standard Chartered GBA Business Confidence Index' 2020-06-23T21:28:59Z standard-chartered-and-hktdc-launch-standard-chartered-gba-business-confidence-index HONG KONG, June 22, 2020 - (ACN Newswire) - Standard Chartered and Hong Kong Trade Development Council ("HKTDC") are pleased to announce the launch of the 'Standard Chartered GBA Business Confidence Index', the first forward-looking quarterly survey in the market that looks at the business sentiment and synergistic effects across cities and industries in the Guangdong-Hong Kong-Macao Greater Bay Area (Greater Bay Area or GBA), to provide the latest business intelligence for those who are keen to grow their presence in the Greater Bay Area. Standard Chartered: Kelvin Lau, Senior Economist, Greater China; Rose Kay, Head, Greater Bay Area; Mary Huen, CEO, Hong Kong - HKTDC: Margaret Fong, Executive Director; Johnny Wan, Director, Publications & E-Commerce; and Nicholas Kwan, Director of Research, 'Standard Chartered GBA Business Confidence Index' launch ceremony (6/22). The index will be released every quarter and is computed from the analysis of more than 1,000 responses of GBA companies on their overall operations, business environment and expansion plan. The index includes five sub-indices which give indications on the business confidence for each industry, including manufacturing & trading, retail & wholesale, financial services, professional services and innovation & technology. It enables investors and businesses to better understand the current business climate, gauge future performance and formulate their market strategies in the Greater Bay Area.Mary Huen, CEO, Hong Kong, Standard Chartered, said: "We are very pleased to join forces with the HKTDC to introduce the first GBA business confidence index in the market. We believe that the survey will help the public and companies in the region make appropriate strategic decision with economic insight in today's ever-changing market environment. The Greater Bay Area is one of the biggest growth drivers of the Chinese economy and plays a significant role in the opening of China and gives companies in the region full play to the composite advantages of Guangdong, Hong Kong and Macao. It will also help promote coordinated regional economic development and inject new impetus into the diversified development of Hong Kong economy. Standard Chartered will endeavour to expand our business in the region and would like to leverage its talents and technology in finance to develop our innovative financial products and services."Margaret Fong, Executive Director, HKTDC, said: "We are delighted to collaborate with the Standard Chartered again. By launching the first GBA Business Confidence Index in the market, we can assist businesses to formulate timely development plans and capture new opportunities. The HKTDC has signed agreements with the other 10 Greater Bay Area cities to facilitate companies in the region to expand their businesses through Hong Kong's two-way platform, strengthening the city's position as the region's global investment and business hub. Going forward, we will help businesses tap into Greater Bay Area markets by providing them with intelligence, promotion and business matching opportunities through our exhibitions, conferences, missions and more."As a leading global bank with extensive branch network in the Greater Bay Area, Standard Chartered has been promoting the local economic development and put it as one of its key strategic priorities. Our unique global footprint and business expertise such as Belt and Road, RMB internationalisation, trade finance, bond market, digital innovation, wealth management and sustainable finance can meet the financial needs in the development of the Greater Bay Area.About Standard CharteredWe are a leading international banking group, with a presence in 59 of the world's most dynamic markets, and serving clients in a further 85. Our purpose is to drive commerce and prosperity through our unique diversity, and our heritage and values are expressed in our brand promise, Here for good.Standard Chartered PLC is listed on the London and Hong Kong Stock Exchanges as well as the Bombay and National Stock Exchanges in India.The history of Standard Chartered in Hong Kong dates back to 1859. It is currently one of the Hong Kong SAR's three note-issuing banks. Standard Chartered incorporated its Hong Kong business on 1 July 2004, and now operates as a licensed bank in Hong Kong under the name of Standard Chartered Bank (Hong Kong) Limited, a wholly owned subsidiary of Standard Chartered PLC.For more stories and expert opinions please visit Insights at sc.com. Follow Standard Chartered on Twitter, LinkedIn and Facebook.About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via trade publications, research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.For further information, please contact:Standard Chartered Bank (Hong Kong) LimitedGabriel Kwan / Daniel IpTel: +852 2820 3036 / +852 2820 3871Email: gabriel.kwan@sc.com / daniel.ip@sc.comHong Kong Trade Development CouncilBeatrice LamTel: +852 2584 4049Email: Beatrice.hy.lam@hktdc.org Werner Erhard and Martin Heidegger On Being 2020-06-17T23:13:59Z werner-erhard-and-martin-heidegger-on-being Groundbreaking ideas introduced to a new generation of thinkers via bestselling book. Erhard's transformational ontological work and Heidegger's philosophical work brought together for the first time. June 18, 2020 - During these challenging times of uncertainty and disruption, we are spending many hours with our attention on what's no longer available to us and what might happen and might not happen. Perhaps for that reason alone, the new book "Speaking Being", has never been more relevant."Speaking Being: Werner Erhard, Martin Heidegger, and a New Possibility of Being Human" (Wiley), an Amazon #1 bestseller in Philosophy, is an opportunity to bring our focus to the relatively unexamined world of being.Professors Bruce Hyde's (PhD) and Drew Kopp's (PhD) highly acclaimed book offers an unprecedented study of the ideas and methods developed by Martin Heidegger, one of the most prominent philosophers of the 20th century, and the ideas of Werner Erhard, the breakthrough thinker who created The Forum program in the 1980s (following his est Training in the 1970s).Through a comparative side-by-side display and analysis of a transcript of Erhard's Forum, with his ideas and methodology, combined with Heidegger's philosophical ideas, the authors make the power of Erhard's ontological rhetoric and Heidegger's often difficult-for-the-layman ideas available to a wide range of audiences. It brings to life complex yet important new ideas for scholars at work within a variety of academic disciplines, and provides an entry to anyone interested in the possibility of and the access to being for human beings. In accomplishing all of this, what is revealed are new insights into the actual nature of being of human beings, and the opening up of new possibilities for being for human beings.Jonathan D. Moreno, Professor of Ethics at University of Pennsylvania, said Speaking Being is "powerful, imaginative, frustrating, amusing, threatening, and enlightening - all at the same time. It also has the power to transform your life."Michael E. Zimmerman, Professor Emeritus, University of Colorado, Boulder stated, "I regard Speaking Being as an enormously important contribution to understanding Heidegger and Erhard. The latter has received far too little serious academic attention, and this book begins to make up for that lack. Moreover, the book's analysis of Heidegger's thought is among the best that I have ever read. I commend this book to all readers without reservation." Indonesian Minister of Social Affairs Describes Key Steps to Overcoming the Impact of COVID-19 2020-06-14T15:29:28Z indonesian-minister-of-social-affairs-describes-key-steps-to-overcoming-the-impact-of-covid-19      June 12, 2020 - In the presence of the ASEAN Minister, the Indonesian Minister of Social Affairs Juliari P. Batubara conveyed the government's important steps in handling the impact of the COVID-19 pandemic, particularly for the poor and vulnerable groups. Indonesia recommends the establishment of a comprehensive and sustainable social protection system.   Indonesian Minister of Social Affairs Juliari P. Batubara "To the ASEAN ministers, I convey comprehensive and quick steps of the Indonesian government in handling the impact of the COVID-19 pandemic. In the context of the Ministry of Social Affairs' duties and functions, the government has increased the index and expanded the social assistance, especially for the poor and vulnerable groups," said the Minister of Social Affairs Juliari after the meeting (10/06).The meeting was held online and opened by ASEAN Secretary General Dato 'Lim Jock Hoi and attended by 10 ASEAN member Ministers dealing with social welfare issues.In a meeting with the theme "Special Online Meeting of the ASEAN Ministerial Meeting on Social Welfare and Development (AMMSWD) on Mitigating Impact of COVID-19 on Vulnerable Groups in ASEAN," Social Minister Juliari acted as Chair of the Indonesian Delegation.On that occasion, the Minister of Social Affairs delivered four important steps in mitigating the socio-economic impact of the pandemic, especially for the poor and vulnerable groups. The first step is increasing the number and coverage of social assistance and social safety nets, and the amount of assistance for several social protection programs.Second, strengthening government investment in the development of Integrated Social Welfare Data (DTKS) and formulating an adaptive social protection platform in accordance with the 2019-2024 National Medium-Term Development Plan (RPJMN) and Ministry of Social Affairs Strategic Plan 2020-2024. Then, the fourth is the crucial role of social solidarity."The government continues to increase commitment and serious steps in dealing with the impact of the pandemic. In the new (fourth) fiscal stimulus, the government allocates a budget of Rp677.2 trillion, of which Rp203.9 trillion is for social protection," said the Minister.This amount increased, compared to the third fiscal stimulus which amounted to Rp405.1 trillion, which for social protection amounted to Rp110 trillion. Social Minister explained, in order to deal with the impact of COVID-19, the government increased the index and expanded the participation of regular social assistance.The Social Assistance of Hope Family Program (PKH) reaches 10 million of Beneficiary Families (KPM). From the beginning KPM received benefits every three months, now it becomes every month, starting in April-December 2020, so that KPM PKH got a double benefit.Then, in the Sembako Program (Non-Cash Food Aid / BPNT), the target expansion and the increasing index is carried out, from 15.2 million KPM to 20 million KPM, with an index from Rp 150 thousand to Rp 200 thousand.The Ministry of Social Affairs also launched a non-regular social assistance program namely the Presidential Assistance of Staple Food Package (Banpres) and Cash Social Assistance (BST). Banpres began to be distributed to communities affected by COVID-19 in DKI Jakarta, Bogor Regency, Tangerang City and South Tangerang, Depok and Bekasi (Jabodetabek), on 20 April.The Banpres reaches 1.9 million families (KK) with a value of Rp. 600,000 distributed twice a month, so the total value is around Rp. 3.4 trillion.While BST, it reaches 9 million families outside Jabodetabek who have not received the Family Hope Program (PKH) and the Sembako Program (Non-Cash Food Assistance) with a value of Rp. 600,000/KK/month. Both Banpres and BST, it was distributed for three months -- April, May, and June 2020."With the latest stimulus of Rp. 677, 2 trillion, the government has extended the assistance until December 2020," said the father of two children.The Minister also stressed the importance of managing poverty data or Integrated Social Welfare Data (DTKS), which is the basis for various social assistances. "DTKS contains 40% of the lowest income people in Indonesia. And with DTKS, it is very helpful in ensuring that social assistance is distributed on target," said the Minister.Bureau of Public RelationsMinistry of Social Affairs of the Republic of Indonesia Pacific Green Provides Business Activities Update 2020-06-13T01:29:49Z pacific-green-provides-business-activities-update      June 13, 2020 - Pacific Green Technologies, Inc. (the "Company" or "PGTK") (OTCQB:PGTK), developer of the ENVI-Marine(TM) emission control system (the "System"), today provides an update on the impact of the Pandemic on its business activities.Since entering the marine sector, the Company has delivered 86 ENVI-Marine(TM) Systems to its customers, with another 56 ENVI-Marine(TM) Systems contracted to be delivered in 2020 and 2021. Travel restrictions resulting from the Pandemic have impeded the Company's ability to enter and exit shipyards. The Company has postponed 32 ENVI-Marine(TM) System installations to 2021 to accommodate client and supplier needs but has received no ENVI-Marine System cancellations as a result of the Pandemic.The Company can report the successful registration in China of its joint venture company with partner PowerChina SPEM. The joint venture, along with the ongoing integration of Shanghai Engin Digital Technology Co. Ltd., ("Engin"), which was acquired by PGTK in December 2019, has positioned the Company to take advantage of the rapidly growing renewables market around the world in concentrated solar power (CSP), desalination and waste-to-energy (WtE).The Company is also pleased to announce that it has made significant progress in developing its business relationships in India. By 2022, an additional 175 GW of electrical capacity in India is forecasted to require Flue Gas Desulphurization (FGD) (source: Centre for Science and Environment, India), which PGTK's efficient ENVI-Clean(TM) Systems are well suited to deliver.The Company has continued its obligation to maintain shareholder value on behalf of its shareholders. The Company has embarked on an aggressive cost-cutting campaign and restructured its operations to maintain its strong financial position despite the global economic strain and uncertainty created by the Pandemic.Scott Poulter, Chief Executive, said: "We have been working hard with our clients and suppliers to ease the collective strain that the Pandemic has imposed on our business and the business of our partners and stakeholders.We are pleased to see increasing interest in our newly acquired solar and desalination technologies across a number of different regions. These opportunities will complement our highly-efficient emission control technologies, which have allowed us to target the massive FGD and WtE markets.The Pandemic has had a devastating effect on lives and livelihoods. Hopefully, the world will take a new look at how we live and how we treat our environment as the two should go hand in hand."About Pacific Green Technologies, Inc.Pacific Green Technologies, Inc. (OTCQB:PGTK) is focused on addressing the world's need for cleaner and more sustainable energy. The company's strategy is to build through organic development and acquisition, a portfolio of patented competitive cutting-edge technologies designed to meet the growing market for renewables and increasingly stringent environmental standards. For more information, visit PGTK's website: www.pacificgreentechnologies.com Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus 2020-05-20T12:24:16Z strong-effectiveness-of-nanoviricides-drug-candidates-observed-in-an-animal-model-of-infection-by-an-ace2-using-human-coronavirus      May 20, 2020 - NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced today that strong effectiveness against infection by an ACE2-utilizing coronavirus in an animal model has been observed for the drug candidates it is developing against SARS-CoV-2 to treat COVID-19 spectrum of diseases.NanoViricides is developing an animal model for coronavirus infection using hCoV-NL63 as a surrogate for SARS-CoV-2, the virus that causes COVID-19 disease. HCoV-NL63 is a circulating human coronavirus that causes a disease that is similar to SARS-CoV-2, but much milder. Both viruses utilize the same cell receptor, namely ACE2, to gain entry into the cell. Because it causes a mild disease, hCoV-NL63 can be used in BSL2 environments, and the Company believes it is a useful surrogate for development of therapeutics against SARS-CoV-2 infection.In this lethal direct-lung-infection model, animals in all groups developed lung disease which later led to multi-organ failures, a clinical pathology resembling that of the SARS-CoV-2. Reduction in loss of body weight at day 7 was used as the primary indicator of drug effectiveness. Rats were infected directly into lungs with lethal amounts of hCoV-NL63 virus particles and then different groups were treated separately with five different nanoviricides drug candidates, remdesivir as a positive control, and the vehicle as a negative control. The treatment was intravenous by tail-vein injection once daily for five days, except in the case of remdesivir wherein it was by tail-vein injection twice daily.Animals treated with the five different nanoviricides showed significantly reduced body weight loss. The body weight loss was only 3.9% for the best nanoviricide candidate, ranging to 11.2% for the potentially least effective one, as compared to 20% in the vehicle-treated control group, in female animals (n=5 in each group). Male animals treated with the same nanoviricides also showed significantly reduced body weight loss. The body weight loss in male animals was 8.0% for the best nanoviricide candidate and ranged up to 10.9% for the potentially least effective one, as compared to 25% in the vehicle-treated control group (n=5 in each group). In comparison, remdesivir treatment led to a body weight loss of 15.2% in females and 18.6% in males in this study (see below). Smaller numbers mean less loss in body weight compared to starting body weight in the group, and indicate greater drug effectiveness.The strong effectiveness of nanoviricide drug candidates in this model is consistent with the effectiveness observed in cell culture studies against infection of both hCoV-NL63, which was used in this study, and hCoV-229E, another circulating coronavirus that uses a distinctly different receptor, namely APN.Thus this study corroborates the previous cell-culture effectiveness reported by the Company and provides confidence to the Company that these nanoviricides drug candidates may be expected to result in a clinical candidate to be pursued in human clinical trials.The Company believes the fact that these nanoviricides anti-coronavirus drug candidates are highly effective against two distinctly different coronaviruses that use different cellular receptors is very significant. Specifically, it provides a rational basis to scientists indicating that even if the SARS-CoV-2 coronavirus mutates, the nanoviricides can be expected to continue to remain effective.Importantly, nanoviricides are designed to act by a novel mechanism of action, trapping the virus particle like the "Venus-fly-trap" flower does for insects. Antibodies, in contrast, only label the virus for other components of the immune system to take care of. It is well known that the immune system is not functioning properly at least in severe COVID-19 patients.The Company believes that these nanoviricides drug candidates are potentially superior to favipravir, based on cell culture studies and may be superior to remdesivir based on the results of this study, however, a definite conclusion to that effect cannot be drawn. Oral favipravir and infusion of remdesivir are two anti-viral drugs in clinical trials for the treatment of COVID-19.Prior to filing for human clinical trials, NanoViricides plans on conducting studies to further determine the effectiveness against SARS-CoV-2, perform drug development studies for safety/toxicology, and request a pre-IND Meeting with the US FDA for regulatory guidance.Human coronavirus NL63 (hCoV-NL63) uses the same ACE2 receptor as the SARS-CoV-2 that causes CoVID-19. Both in terms of its clinical pathology, and its receptor usage, it is known to be very similar to SARS-CoV-2, except much milder. Therefore the Company believes hCoV-NL63 is a good surrogate model for therapeutics development against SARS-CoV-2. HCoV-NL63 can be studied in a BSL2 lab whereas SARS-CoV-2 currently requires a BSL3 or BSL4 facility.The striking difference in weight loss between the two sexes in this animal model was remarkable. It has been widely reported that men are more likely to suffer severe infection and fatalities from SARS-CoV-2 than women in the current pandemic. This feature was replicated in our animal model study indicating that biological sex differences are the driver of the differences in the severity of infection by the coronaviruses that utilize the ACE2 receptor.The various receptors used by different coronaviruses appear to fall in the broad family of membrane-associated serine proteases. As a family, they share several structural features. Their substrate specificities are dictated by specific amino acid residues and their positions. However, the coronaviruses do not appear to insert into the specific substrate sites on their receptors as can be broadly deduced from limited, available knowledge of these interactions. NanoViricides believes that this has made it possible for the Company to develop receptor-mimetic virus-binding ligands that have broad-spectrum effectiveness against multiple coronaviruses that use different receptors.HCoV-NL63 is known to cause severe lower respiratory tract infections in young children leading to hospitalization. The symptoms are generally less severe than SARS-CoV-2 but are similar. In most cases, hCoV-NL63 causes relatively mild disease, often associated with croup, bronchiolitis, and lower respiratory tract disease in children, and is considered to cause some of the common colds in adults. Thus, the clinical manifestation of hCoV-NL63 infection in pediatric patients is similar to that of SARS-CoV-2, although much less severe. SARS-CoV-2 causes clinically similar milder forms of disease in most patients, but moderate to severe disease requiring hospitalizations in about 15-20% of infected persons. These similarities imply that hCoV-NL63 should be a reasonable model virus for antiviral cell culture and animal studies in BSL2 environment in the course of antiviral drug development for SARS-CoV-2.About NanoViricidesNanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide(R) class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. The Company's technology is based on broad, exclusive, sub-licensable, field licenses to drugs developed in these areas from TheraCour Pharma, Inc. The Company does not currently have a license to the coronavirus field, however, TheraCour has not denied any licenses to the Company. The Company typically begins the licensing process only after demonstrating effectiveness of some candidates in optimization stage.This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.As with any drug development efforts, there can be no assurance that any of these candidates would show sufficient effectiveness and safety for human clinical development at this time.There can be no assurance that the Company will be successful in establishing the necessary collaborations, although the Company has been successful at establishing necessary collaborations for its drug programs in the past.FDA refers to US Food and Drug Administration. IND application refers to "Investigational New Drug" application. CMC refers to "Chemistry, Manufacture, and Controls". Trintech Releases 2020 Global Record to Report Benchmark Report 2020-05-12T16:09:38Z trintech-releases-2020-global-record-to-report-benchmark-report      May 13, 2020 - Trintech, a leading provider of financial software solutions, today announced the release of its 2020 Global Record to Report Benchmark Report. Trintech surveyed almost 200 enterprise companies across 31 countries through January 2020 to evaluate which parts of the Record to Report (R2R) process have been automated, which are in the process of being automated and where finance and accounting (F&A) organizations are looking to adopt automation in the future.Key findings from the survey on the trends in R2R automation include:- Reconciliations are currently the single biggest challenge for F&A organizations- A growing number of organizations identify a lack of standardization across all processes as their main roadblock to efficiency- Looking ahead to 2025, respondents expect their biggest challenges will be personnel related, as attracting and retaining talent becomes more critical"Automating low-value, repetitive tasks completed by the office of finance is finally starting to gain traction - we see the interest in the benefits of financial automation growing each year," said David King, Chief Marketing Officer at Trintech. "These insights show that there is a huge potential for organizations to achieve significant ROI through the implementation of automation technology. Now, more than ever, organizations are looking for ways to be more efficient, while increasing transparency and ensuring data integrity as part of their month end or quarter end close. The office of finance is providing insights almost daily now that are crucial for business decisions across every industry."In terms of organizations' current automation practices, only 20% of respondents have "Established" or "Advanced" automation in place. The report's findings also show that most organizations are at least starting the move towards automating some parts of their office of finance, and there are few laggards that have not started implementing automation at all."Organizations need to spend more time understanding risk and less time managing data - approaches that deliver that efficiently and effectively, and drive quality into the process, have immense value," said Jim O'Connor, Managing Principal Advisory Practice at The Hackett Group.To dive into the results of this benchmark report further, Trintech and The Hackett Group will be hosting a joint webinar, How to Prepare Your Organization for the Future of Financial Automation, on Thursday, May 14th, to give companies insight into topics such as:- The biggest challenges for the month end process- Roadblocks to having the most efficient process- The maturity of financial close automation- Key areas to focus on improving by 2025Read the full Record to Report (R2R) Benchmark Report here. https://pr.report/H8G3eY14About TrintechTrintech Inc., a pioneer of Financial Corporate Performance Management (FCPM) software, combines unmatched technical and financial expertise to create innovative, cloud-based software solutions that deliver world-class financial operations and insights. From high volume transaction matching and streamlining daily operational reconciliations, to automating and managing balance sheet reconciliations, intercompany accounting, journal entries, disclosure reporting and bank fee analysis, to governance, risk and compliance - Trintech's portfolio of financial solutions, including Cadency(R) Platform, Adra(R) Suite, and targeted tools, ReconNET(TM), T-Recs(R), and UPCS(R), help manage all aspects of the financial close process. Over 3,500 clients worldwide - including the majority of the Fortune 100 - rely on the company's cloud-based software to continuously improve the efficiency, reliability, and strategic insights of their financial operations.Headquartered in Dallas, Texas, Trintech has offices located across the United States, United Kingdom, Australia, Singapore, France, Germany, Ireland, the Netherlands and the Nordics, as well as strategic partners in South Africa, Latin America and the Asia Pacific. To learn more about Trintech, visit www.trintech.com or connect with us on LinkedIn, Facebook and Twitter.About The Hackett GroupThe Hackett Group (NASDAQ: HCKT) is an intellectual property-based strategic consultancy and leading benchmarking and best practices firm to global companies, with offerings that include smart automation and enterprise cloud application implementation. Services include business transformation, enterprise analytics, global business services, and working capital management. The Hackett Group also provides dedicated expertise in business strategy, operations, finance, human capital management, strategic sourcing, procurement and information technology, including its award-winning Oracle and SAP practices.The Hackett Group has completed nearly 18,000 benchmarking studies with major corporations and government agencies, including 93% of the Dow Jones Industrials, 90% of the Fortune 100, 80% of the DAX 30 and 57% of the FTSE 100. These studies drive its Best Practice Intelligence Center(TM) which includes the firm's benchmarking metrics, best practices repository and best practice configuration guides and process flows, which enable The Hackett Group's clients and partners to achieve world-class performance.More information on The Hackett Group is available at: www.thehackettgroup.com, info@thehackettgroup.com, or by calling (770) 225-3600. Cyber Company to Supply 50M Health "COVI-PASS(TM)" 2020-05-08T06:56:17Z cyber-company-to-supply-50m-health-covi-pass-tm      - Cyber tech company signs technology deal to supply 50M "COVI-PASS(TM)" Digital Health Passports to 15 countries- VST Enterprises signs deal with digital health technology company - Circle Pass Enterprises - to supply its patented VCode(R) technologies to create the world's most secure digital health passport - COVI-PASS(TM)- Cyber Company is committed to working closely with governments & major stakeholders to deploy safe & trusted technology solution for COVID-19 pandemic May 8, 2020 - International Digital Health Technology firm Circle Pass Enterprises (CPE) has signed a deal with VST Enterprises Ltd (VSTE) the British cyber security company founded by tech entrepreneur Louis-James Davis (31) to integrate its state-of-the-art VCode(R) & VPlatform(R) technologies into the COVI-PASS(TM) Digital Health Passport. Louis-James Davis CEO VST Enterprises Powered by VST Enterprises groundbreaking cyber security technology VCode(R) & VPlatform(R), Circle Pass Enterprises has contracted with VST Enterprises for a fully secure Digital Health Passport - COVI-PASS(TM), to be paired with approved testing kits. CPE is to start shipping orders from next week for the first phased release of 50M COVI-PASS(TM) Digital Health Passports to both the private sector and Governments in over 15 countries, including Italy, Portugal, France, Panama, India, the US, Canada, Sweden, Spain, South Africa, Mexico, United Arab Emirates and The Netherlands.The COVI-PASS(TM) Digital Health Passport works on an intelligent colour mapping system (green, amber, red) to authenticate and validate a COVID-19 test providing test history and relevant health information. This allows for accurate data metrics to assess those who have tested positive and negative and the location only of their testing. The COVI-PASS(TM) Digital Health Passport can be used as an authenticated gateway for Public Services, Businesses and Employees to manage a safe return to work, life, and safe travel.Commenting on the deal VST Enterprises CEO Louis-James Davis said; "We are delighted to be working with CPE to supply our VCode(R) & VPlatform(R) technology and Digital Health Passport to create COVI-PASS(TM). It is also very encouraging that so many Governments and Enterprises across the world are engaging and using the COVI-PASS(TM) Health Passport and approved testing kits.We firmly believe that the digital Health Passport alongside Government approved testing kits is the key to removing the lockdown restrictions in a gradual and controlled way. The current technology being trialed using bluetooth and proximity apps is fundamentally flawed because of its privacy issues of real time tracking, the security and data breaches which we are already seeing and being reported and the reticence for citizens to uptake and download the tracing app."The Manchester based company are also in advanced discussions with senior UK Government officials, NHSX the technology arm of the NHS and the Home Office about its cyber security technology. The cyber security technology developed by VSTE can be used by various sectors including critical care workers doctors, nurses and health workers in the NHS and blue light emergency services key workers. Using a VCode(R) integrated with a health passport would help get them back on the front line in a safe and controlled manner.Circle Pass Enterprises COO and Co Founder Adam Palmer said; "We are delighted to be working with Louis-James Davis and VST Enterprises to utilise the ground breaking cyber security technology of VCode(R) & VPlatform(R) to create COVI-PASS(TM) and to help tackle this global pandemic. One of the many unique features of the VCode(R) cyber security is that the VCode(R) technology can be scanned from up to 100 metres ensuring its social distancing compliance is robust and making it the only choice for a safe and secure digital health passport.We are seeing unprecedented levels of interest from Governments, Businesses and major sporting organisations for the COVI-PASS(TM) solution. Due to the secure patented technology of the VCode(R) & VPlatform(R) - its ease of use and rapid implementation globally across all sectors - it is clear that COVI-PASS(TM) is the only viable solution for a safe return to work, life and travel protocols. Unlike Bluetooth, QR, or similar proximity apps, COVI-PASS(TM) using the VCode(R) & VPlatform(R) cyber security tech does not violate privacy issues of the user."VSTE are also providing its VCode(R) & VPlatform(R) technology to work with the UNITED NATIONS as part of their SDG Collaboratory (Sustainable Development Goals) program - to provide a wide range of technology services to 9 Billion people by 2030 and which will be announced in the coming weeks.VSTE and its partner REDSTRIKE the sports marketing agency are also in advanced discussions with major global sporting organisations and regulatory bodies in F1, motorsport, football, rugby, athletics, cycling, golf, tennis and basketball, to use its VCode(R) technology to help kick start the global sports economy.REDSTRIKE MD Mike Farnan - the former Manchester United FC International MD - and his team have been pivotal in opening up high level talks with global sporting organisations.The "COVI-PASS(TM)" Health Passport User JourneyA short infomercial explains the technology at www.covipass.com- The user downloads the app to their smartphone device and onboards their key information such as name, address, age and verifies their identity using biometric fingerprint or facial scan.- The user then takes the COVID-19 test which is administered by an authorised Health Care Professional, Nurse or Doctor. The test is geo fenced to that location and the test results are then scanned from the testing kit into the COVI-PASS(TM) Health Passport.- A traffic light system then confirms their health status as either red or green, red for positive and green for negative. The amber colour indicates a countdown timer to when another test would be due and required.- The user can then show the COVI-PASS(TM) health passport to authenticate their health status. The health passport can also be scanned well outside the safe distancing zone of 2/3m (and beyond) while the person is moving and at various angles to ensure continued social distancing guidelines.VST Enterprises CEO Louis-James Davis added; "The issue at present with other health passports is that not only is the feed of information voluntary, but the technology being used (in most cases a QR code or barcode) can't be interacted with outside of the safe distancing zone. Data and sensitive information scanned or stored in either a QR code and barcode can be hacked and are inherently insecure, leaving data and personal details to be compromised. Both barcodes and QR codes are old second generation technology. VCode(R) & VPlatform(R) represent the next "third generation" of ultra secure and versatile code technology to military grade encryption with over 2 Quintillion code permutations.The technology used in contact tracing and Bluetooth proximity apps currently being used by various Governments is fundamentally flawed. Not only can the bluetooth app and its data be compromised and hacked, but it can also lead to false flag data. There are also real fundamental issues of privacy, and being tracked in real time which most citizens will resist at all levels. This will also contribute to anxiety about the technology thus resulting in poor uptake. Without 100% uptake of the population using the technology its data is ineffective, and does not give a true picture of the virus tracing. Add into this the fact that bluetooth can also penetrate glass and walls. So someone for example, who is self isolating in a house that has tested positive for COVID-19 would give off a false flag to someone walking past their house who has tested negative, that they had been in proximity to someone who has tested positive."NOTES TO EDITORSAbout VST Enterprises LtdVST Enterprises (VSTE) is the company behind the VCode(R) and VPlatform(R). Headquartered in Manchester, the company has satellite offices around the world and is operational in 16 countries.About VCode(R) & VPlatform(R)VCode(R) represents the next generation of code scanning technology - an evolutionary step forward from traditional barcodes and QR Codes. VCode(R) has an infinite range of applications and capabilities from secure identification and ID, to geo location and geo fencing, asset tracking, authentication and permission based authorisations, fan and customer engagement through to biometrics and facial recognition.VCode(R) can be used across a wide range of applications to securely purchase music, video and film content to concert and sports event tickets. It can also be used to screen exclusive film content, sales promotion and marketing and create dynamic marketing and fan engagement campaigns. Its wider uses also include anti counterfeiting and anti piracy.A VCode(R) can be scanned from over 100 metres, with a 80:1 distance to size scan ratio, at 170-degree angles, on and from moving objects, and upon any multimedia or television screen and even when the VCode(R) is microscopic on bank notes or minerals. This allows users to access exclusive content, check the validity and authenticity of an item and make purchases while on the move. VCode(R) provides military grade encryption with over 2.2 Quintillion combination codes.Supporting the VCode(R) app is the VPlatform(R) - a secure cloud based portal that allows users to create VCode(R) and manage the content they lead to. The VPlatform(R) also provides users with real time analytics on who scanned their codes, when and where the scans took place, providing vital consumer data.The VPlatform(R) enables push notifications and rewards to be sent back to individuals who have made VCode(R) scans, offering opportunities for brands to significantly enhance their engagement levels with their client base. For more information please visit www.vstenterprises.com or www.vcode.it/developersAbout Circle Pass Enterprises (COVI-PASS(TM))Circle Pass Enterprises (CPE) is a global Digital Health Technology Company. Circle Pass Enterprises, which owns COVI-PASS(TM), has offices in London, Dublin, Amsterdam, Dubai, New York, Hong Kong and Chennai. Supported by a number of leading scientists and medical professionals, the CPE executive leadership team are developing digital Health Technology solutions for global application. For more information please visit www.covipass.com Trintech Extends Reporting Capabilities in Its Adra Suite with the Launch of Adra Analytics 2020-05-04T16:09:45Z trintech-extends-reporting-capabilities-in-its-adra-suite-with-the-launch-of-adra-analytics      May 5, 2020 - As a leading provider of financial software solutions, Trintech today announced the launch of Adra Analytics, extending the reporting capabilities of its Adra Suite. This solution ensures companies have full visibility into their financial data in one consolidated location, giving them a one-stop-shop for all their financial reporting needs."Adra Analytics has given us full visibility into the quality and efficiency of our close process," said Wojciech Bec, Financial Controller at Unit4. "We can identify which areas we are doing well, and which areas need improvement. This insight has enabled us to accelerate our financial close process significantly."With Adra Analytics, organizations can now track the trends and movements of their financial data throughout one period, or over several, to give them greater insight into how their company is maturing. It allows organizations to combine financial data within the Adra Suite with data from other solutions, such as their ERP, through a BI toolkit, to give them complete insight into their month-end alongside non-close related activities. Through customized dashboards organizations gain visibility into high-level summaries of their data and they also provide the ability to deep dive into the details required to analyze how their month-end is impacting the overall company's financials."As a leading financial software provider, we know that a company's financial data is mission critical, especially during a time like this," said Darren Heffernan, President, Mid-Market at Trintech. "Finance & Accounting (F&A) organizations are even more integral to their businesses because they have the data that are driving those immediate business decisions. To help provide that real-time visibility into the financials, we are thrilled to announce the launch of Adra Analytics that will help F&A organizations gain those insights quickly to help drive the strategic directions of their organizations."Currently deployed by over 1,800 companies across the globe, the Adra Suite provides cloud-based, financial close and reconciliation solutions for companies looking to quickly increase the efficiency, control and visibility for all key areas of the financial close process including: balance sheet reconciliations (Adra Balancer), transaction matching (Adra Matcher), financial task management and controls (Adra Task Manager), and reporting (Adra Analytics).About TrintechTrintech Inc., a pioneer of Financial Corporate Performance Management (FCPM) software, combines unmatched technical and financial expertise to create innovative, cloud-based software solutions that deliver world-class financial operations and insights. From high volume transaction matching and streamlining daily operational reconciliations, to automating and managing balance sheet reconciliations, intercompany accounting, journal entries, disclosure reporting and bank fee analysis, to governance, risk and compliance - Trintech's portfolio of financial solutions, including Cadency(R) Platform, Adra(R) Suite, and targeted tools, ReconNET(TM), T-Recs(R), and UPCS(R), help manage all aspects of the financial close process. Over 3,500 clients worldwide - including the majority of the Fortune 100 - rely on the company's cloud-based software to continuously improve the efficiency, reliability, and strategic insights of their financial operations.Headquartered in Dallas, Texas, Trintech has offices located across the United States, United Kingdom, Australia, Singapore, France, Germany, Ireland, the Netherlands and the Nordics, as well as strategic partners in South Africa, Latin America and the Asia Pacific. To learn more about Trintech, visit www.trintech.com or connect with us on LinkedIn, Facebook and Twitter. Trintech and The Hackett Group Announce Strategic Partnership to Help Organizations Transform the Close 2020-04-22T17:15:42Z trintech-and-the-hackett-group-announce-strategic-partnership-to-help-organizations-transform-the-close Apr 23, 2020 - Trintech, a leading global provider of integrated Record to Report software solutions for the office of finance, and The Hackett Group, Inc. (HCKT), an intellectual property-based strategic consultancy and leading enterprise benchmarking and best practices digital transformation firm to global companies, today jointly announced a strategic alliance to deliver finance solutions that empower organizations to deliver real-time financial intelligence to executives and add strategic value to the enterprise."The demand for Record to Report technology solutions continues to grow as finance organizations around the world seek to increase not only the efficiency, but also the effectiveness of their financial close," said David Dungan, Vice Chairman and COO of The Hackett Group. "We believe this strategic partnership with Trintech will offer customers a comprehensive solution that will drive true financial transformation."With this strategic alliance, Trintech and The Hackett Group will provide CFO and CIO organizations with effective finance processes and technology solutions that optimize efficiencies, visibility, governance and controls across the entire Record to Report process. By improving and automating these operations, Trintech and The Hackett Group will help the office of the CFO reduce costs and risk and allow them to free up valuable resources to refocus their time and effort on other initiatives critical to the business."We are confident that organizations committed to digitally enabling and transforming their financial processes will benefit immensely from the combination of Trintech's System of Accounting Intelligence(TM) and The Hackett Group's expertise in helping businesses simplify, standardize, and automate their processes," said Russ Hubbard, Chief Revenue Officer at Trintech. "Together, we aim to help finance organizations become simpler, agile and more efficient."With this partnership, Trintech's customers will be able to extend and augment the benefits they have experienced from utilizing Trintech's leading Record to Report solution by engaging The Hackett Group's empirical benchmarks, intellectual property, and focused consulting capabilities that detail how companies can improve efficiency and effectiveness and quantify world-class and peer performance. The Hackett Group's research also spotlights strategic thinking in financial transformation strategy, best practices and emerging areas - including the increasing use of digital transformation such as robotic process automation and artificial intelligence.About The Hackett GroupThe Hackett Group (HCKT) is an intellectual property-based strategic consultancy and leading enterprise benchmarking and best practices digital transformation firm to global companies, offering digital transformation including robotic process automation and enterprise cloud application implementation. Services include business transformation, enterprise analytics, working capital management and global business services. The Hackett Group also provides dedicated expertise in business strategy, operations, finance, human capital management, strategic sourcing, procurement and information technology, including its award-winning Oracle and SAP practices.The Hackett Group has completed more than 15,000 benchmarking studies with major corporations and government agencies, including 97% of the Dow Jones Industrials, 89% of the Fortune 100, 87% of the DAX 30 and 59% of the FTSE 100. These studies drive its Best Practice Intelligence Center(TM) which includes the firm's benchmarking metrics, best practices repository and best practice configuration guides and process flows, which enable The Hackett Group's clients and partners to achieve world-class performance.More information on The Hackett Group is available at: www.thehackettgroup.com, info@thehackettgroup.com, or by calling +1-770-225-3600.Hackett Cautionary Statement Regarding "Forward Looking" StatementsThis release contains "forward looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements including without limitation, words such as "expects", "anticipates", "intends", "plans", "believes", seeks", "estimates" or other similar phrases or variations of such words or similar expressions indicating, present or future anticipated or expected occurrences or outcomes are intended to identify such forward looking statements. Forward looking statements are not statements of historical fact and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. Factors that may impact such forward looking statements include without limitation, the ability of Hackett to effectively market and continuing demand for Trintech software, its digital transformation and other consulting services, competition from other consulting and technology companies who may have or develop in the future, similar offerings, the commercial viability of Hackett and its services as well as other risk detailed in Hackett's reports filed with the United States Securities and Exchange Commission. Hackett does not undertake any duty to update this release or any forward looking statements contained herein.About TrintechTrintech Inc., a pioneer of Financial Corporate Performance Management (FCPM) software, combines unmatched technical and financial expertise to create innovative, cloud-based software solutions that deliver world-class financial operations and insights. From high volume transaction matching and streamlining daily operational reconciliations, to automating and managing balance sheet reconciliations, intercompany accounting, journal entries, disclosure reporting and bank fee analysis, to governance, risk and compliance - Trintech's portfolio of financial solutions, including Cadency(R) Platform, Adra(R) Suite, and targeted tools, ReconNET(TM), T-Recs(R), and UPCS(R), help manage all aspects of the financial close process. Over 3,500 clients worldwide - including the majority of the Fortune 100 - rely on the company's cloud-based software to continuously improve the efficiency, reliability, and strategic insights of their financial operations.Headquartered in Dallas, Texas, Trintech has offices located across the United States, United Kingdom, Australia, Singapore, France, Germany, Ireland, the Netherlands and the Nordics, as well as strategic partners in South Africa, Latin America and the Asia Pacific. To learn more about Trintech, visit www.trintech.com or connect with us on LinkedIn, Facebook and Twitter. 2000 km on a Single Charge: Brighsun's Li-S Batteries to Enter Industrial Trials 2020-04-21T21:32:47Z 2000-km-on-a-single-charge-brighsun-s-li-s-batteries-to-enter-industrial-trials FRANKSTON, AUS, Apr 22, 2020 - (ACN Newswire) - Lithium batteries will soon power Electric Vehicles (EVs) traveling 2,000 km on a single charge, say the team at Brighsun New Energy. The company is preparing for industrial trials later in the year for a range of lithium-sulfur (Li-S) batteries that can power a cell phone for over a week and can theoretically travel close to 2,000 km on a single charge. The revolution is underway. Lithium Sulfur (Li-S) Battery Technology BreakthroughThrough nearly 8 years of research, the Brighsun team developed lithium-sulfur (Li-S) batteries with an energy density 5-8 times higher than conventional secondary batteries. According to results from an internationally accredited testing agency (SGS), Brighsun's new technology allows an Li-S battery to keep 91% of its initial capacity after 1,700 cycles at a rate of 2C (being fully charged/discharged in 30 mins). That means the capacity decay per cycle is as low as 0.01%. Even at a more aggressive rate of 5C (being fully charged/discharged in 12.5 mins), Brighsun's Li-S battery retains 74% of its initial capacity after 1,000 cycles (capacity decay per cycle of 0.026%). The cathode energy density for the 1th cycle after activation at charge rate of 1C is 2103.8Wh/kg.Driven by the growing markets world-wide for EVs, the battery industry has explored a range of chemical combinations: lithium iron phosphate, lithium cobalt oxide and, currently, nickel manganese cobalt. However, current battery systems still suffer from the major disadvantages of relatively low energy density, high raw material costs and secondary pollution during recycling.A Game ChangerBrighsun's advanced Li-S chemistry, offering high energy density and resultant low raw material costs, will be a game changer in the EV industry. Li-S batteries also have the potential to become the most promising energy storage systems for future railways, ships and airlines. Industries such as electric supply grid storage, mobile phones, drones and AI will also benefit from dramatically higher energy density storage provided by Brighsun's new battery system.Companies in the US, Germany, Korea and China have been developing Li-S batteries and have achieved promising breakthroughs. However, these systems still face a number of challenges, including volume expansion of cathode materials during cycling, the shuttling effect of polysulfides, and the dendritic growth of lithium on the anode. This results in shorter cycling life and poor fast-charging capability, both major obstacles to their application in the world automotive industry.Brighsun's Revolutionary ApproachBrighsun has patented Li-S battery technology that prevents the generation of polysulfide on the sulfur cathode and effectively suppresses dendritic growth of Li on the anode Li-S, paving the way for Li-S battery use in EVs.The company has already developed processes for the production of cathode materials (electrolytes, separators and lithium sheet anodes), of which the core materials (anodes, electrolytes, and separators) can be produced in batches. Trial production of high-power cells with an expected energy density in excess of 1,000 Wh/kg is about to begin. Brighsun is also developing a solid-state electrolyte compatible with its Li-S system, aiming at further improvements in the cycling life, energy density and safety of its Li-S batteries.Plentiful and Low Cost Battery MaterialsThe main raw materials for Brighsun's Li-S batteries are widely available in Australia, with a supply sufficient for hundreds of years. Indeed, at under AUD100 for 1kWh, the expected production cost of Brighsun-branded 2U Li-S batteries is lower than conventional lithium ion batteries - providing a major boost to the development of electric vehicle and related industries in Australia and around the world.Going ForwardBrighsun is currently in discussion with potential investors in the large-scale trial production of Li-S batteries. The development process for large-scale production is expected to be finished by end-2020, followed by the mass production of Li-S batteries.Brighsun's new energy-dense Li-S battery is expected to accelerate EV take-up around the world, spurred by dramatically improved single-charge travel performance, low cost and long life. Combined with the relative simplicity of EV design compared to internal combustion engine/hybrid vehicles, consumers and the industry alike are set to benefit from lower cost, emission-free transport. At the same time, Brighsun's 2U Li-S batteries offer huge benefits to the mobile phone and solar-electric storage industries, generating dramatic performance improvements in both.About Brighsun EV GroupBrighsun sees its EV technology as a contribution to society's need for more cost effective and less polluting transport. Our Head Office is in Australia and focuses on using new energy technology to produce market ready solutions. Our intellectual property is fully owned by Brighsun and patented in Australia. Our technology comes from our research & development, critical to maintaining our competitive edge. We are building a production base built on our world leading technologies in lithium batteries, and expanding our Zhejiang battery production. For information, please visit http://www.brighsun.com/Index_En.asp.BrighsunSherry XiaoFrankston, Australiakevinhuang@brighsun.comhttp://www.brighsun.com